| Ident. | Authors (with country if any) | Title |
|---|
| 000408 (2017) |
Jedd D. Wolchok ; Vanna Chiarion-Sileni ; Rene Gonzalez ; Piotr Rutkowski ; Jean-Jacques Grob ; C Lance Cowey ; Christopher D. Lao ; John Wagstaff ; Dirk Schadendorf ; Pier F. Ferrucci ; Michael Smylie ; Reinhard Dummer ; Andrew Hill ; David Hogg ; John Haanen ; Matteo S. Carlino ; Oliver Bechter ; Michele Maio ; Ivan Marquez-Rodas ; Massimo Guidoboni ; Grant Mcarthur ; Celeste Lebbé ; Paolo A. Ascierto ; Georgina V. Long ; Jonathan Cebon ; Jeffrey Sosman ; Michael A. Postow ; Margaret K. Callahan ; Dana Walker ; Linda Rollin ; Rafia Bhore ; F Stephen Hodi ; James Larkin | Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. |
| 000411 (2017) |
Ramaswamy Govindan ; Aleksandra Szczesna ; Myung-Ju Ahn ; Claus-Peter Schneider ; Pablo Fernando Gonzalez Mella ; Fabrice Barlesi ; Baohui Han ; Doina Elena Ganea ; Joachim Von Pawel ; Vladimir Vladimirov ; Natalia Fadeeva ; Ki Hyeong Lee ; Takayasu Kurata ; Li Zhang ; Tomohide Tamura ; Pieter E. Postmus ; Jacek Jassem ; Kenneth O'Byrne ; Justin Kopit ; Mingshun Li ; Marina Tschaika ; Martin Reck | Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer. |
| 000531 (2017) |
Michael J. Overman ; Ray Mcdermott ; Joseph L. Leach ; Sara Lonardi ; Heinz-Josef Lenz ; Michael A. Morse ; Jayesh Desai ; Andrew Hill ; Michael Axelson ; Rebecca A. Moss ; Monica V. Goldberg ; Z Alexander Cao ; Jean-Marie Ledeine ; Gregory A. Maglinte ; Scott Kopetz ; Thierry André | Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. |
| 000534 (2017) |
Michele Maio ; Arnaud Scherpereel ; Luana Calabr ; Joachim Aerts ; Susana Cedres Perez ; Alessandra Bearz ; Kristiaan Nackaerts ; Dean A. Fennell ; Dariusz Kowalski ; Anne S. Tsao ; Paul Taylor ; Federica Grosso ; Scott J. Antonia ; Anna K. Nowak ; Maria Taboada ; Martina Puglisi ; Paul K. Stockman ; Hedy L. Kindler | Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial. |
| 000627 (2017) |
Selma Ugurel ; Joachim Röhmel ; Paolo A. Ascierto ; Keith T. Flaherty ; Jean Jacques Grob ; Axel Hauschild ; James Larkin ; Georgina V. Long ; Paul Lorigan ; Grant A. Mcarthur ; Antoni Ribas ; Caroline Robert ; Dirk Schadendorf ; Claus Garbe | Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017. |
| 000640 (2017) |
Dirk Schadendorf ; James Larkin ; Jedd Wolchok ; F Stephen Hodi ; Vanna Chiarion-Sileni ; Rene Gonzalez ; Piotr Rutkowski ; Jean-Jacques Grob ; C Lance Cowey ; Christopher Lao ; John Wagstaff ; Margaret K. Callahan ; Michael A. Postow ; Michael Smylie ; Pier Francesco Ferrucci ; Reinhard Dummer ; Andrew Hill ; Fiona Taylor ; Javier Sabater ; Dana Walker ; Srividya Kotapati ; Amy Abernethy ; Georgina V. Long | Health-related quality of life results from the phase III CheckMate 067 study. |
| 000A68 (2017) |
Josef S. Smolen ; Robert Landewé ; Johannes Bijlsma ; Gerd Burmester ; Katerina Chatzidionysiou ; Maxime Dougados ; Jackie Nam ; Sofia Ramiro ; Marieke Voshaar ; Ronald Van Vollenhoven ; Daniel Aletaha ; Martin Aringer ; Maarten Boers ; Chris D. Buckley ; Frank Buttgereit ; Vivian Bykerk ; Mario Cardiel ; Bernard Combe ; Maurizio Cutolo ; Yvonne Van Eijk-Hustings ; Paul Emery ; Axel Finckh ; Cem Gabay ; Juan Gomez-Reino ; Laure Gossec ; Jacques-Eric Gottenberg ; Johanna M W. Hazes ; Tom Huizinga ; Meghna Jani ; Dmitry Karateev ; Marios Kouloumas ; Tore Kvien ; Zhanguo Li ; Xavier Mariette ; Iain Mcinnes ; Eduardo Mysler ; Peter Nash ; Karel Pavelka ; Gyula Po R ; Christophe Richez ; Piet Van Riel ; Andrea Rubbert-Roth ; Kenneth Saag ; Jose Da Silva ; Tanja Stamm ; Tsutomu Takeuchi ; René Westhovens ; Maarten De Wit ; Désirée Van Der Heijde | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. |
| 000B38 (2017) |
Andrew Blauvelt ; Marjolein De Bruin-Weller ; Melinda Gooderham ; Jennifer C. Cather ; Jamie Weisman ; David Pariser ; Eric L. Simpson ; Kim A. Papp ; H Chih-Ho Hong ; Diana Rubel ; Peter Foley ; Errol Prens ; Christopher E M. Griffiths ; Takafumi Etoh ; Pedro Herranz Pinto ; Ramon M. Pujol ; Jacek C. Szepietowski ; Karel Ettler ; Lajos Kemény ; Xiaoping Zhu ; Bolanle Akinlade ; Thomas Hultsch ; Vera Mastey ; Abhijit Gadkari ; Laurent Eckert ; Nikhil Amin ; Neil M H. Graham ; Gianluca Pirozzi ; Neil Stahl ; George D. Yancopoulos ; Brad Shumel | Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. |
| 000D14 (2017) |
Paolo A. Ascierto ; Michele Del Vecchio ; Caroline Robert ; Andrzej Mackiewicz ; Vanna Chiarion-Sileni ; Ana Arance ; Céleste Lebbé ; Lars Bastholt ; Omid Hamid ; Piotr Rutkowski ; Catriona Mcneil ; Claus Garbe ; Carmen Loquai ; Brigitte Dreno ; Luc Thomas ; Jean-Jacques Grob ; Gabriella Liszkay ; Marta Nyakas ; Ralf Gutzmer ; Joanna Pikiel ; Florent Grange ; Christoph Hoeller ; Virginia Ferraresi ; Michael Smylie ; Dirk Schadendorf ; Laurent Mortier ; Inge Marie Svane ; Delphine Hennicken ; Anila Qureshi ; Michele Maio | Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial. |
| 000F57 (2017) |
Jeffrey S. Weber ; F Stephen Hodi ; Jedd D. Wolchok ; Suzanne L. Topalian ; Dirk Schadendorf ; James Larkin ; Mario Sznol ; Georgina V. Long ; Hewei Li ; Ian M. Waxman ; Joel Jiang ; Caroline Robert | Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma. |
| 001164 (2017) |
Gérard Socié ; Stéphane Vigouroux ; Ibrahim Yakoub-Agha ; Jacques-Olivier Bay ; Sabine Fürst ; Karin Bilger ; Felipe Suarez ; Mauricette Michallet ; Dominique Bron ; Philippe Gard ; Zakaria Medeghri ; Philippe Lehert ; Chinglin Lai ; Tim Corn ; Jean-Paul Vernant | A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. |
| 001237 (2017) |
Tomasz M. Beer ; Eugene D. Kwon ; Charles G. Drake ; Karim Fizazi ; Christopher Logothetis ; Gwenaelle Gravis ; Vinod Ganju ; Jonathan Polikoff ; Fred Saad ; Piotr Humanski ; Josep M. Piulats ; Pablo Gonzalez Mella ; Siobhan S. Ng ; Dirk Jaeger ; Francis X. Parnis ; Fabio A. Franke ; Javier Puente ; Roman Carvajal ; Lisa Sengel V ; M Brent Mchenry ; Arvind Varma ; Alfonsus J. Van Den Eertwegh ; Winald Gerritsen | Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer. |
| 001331 (2017) |
Sandra P. D'Angelo ; James Larkin ; Jeffrey A. Sosman ; Celeste Lebbé ; Benjamin Brady ; Bart Neyns ; Henrik Schmidt ; Jessica C. Hassel ; F Stephen Hodi ; Paul Lorigan ; Kerry J. Savage ; Wilson H. Miller ; Peter Mohr ; Ivan Marquez-Rodas ; Julie Charles ; Martin Kaatz ; Mario Sznol ; Jeffrey S. Weber ; Alexander N. Shoushtari ; Mary Ruisi ; Joel Jiang ; Jedd D. Wolchok | Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis. |
| 001365 (2017) |
Daniel Gaudet ; Gerald F. Watts ; Jennifer G. Robinson ; Pascal Minini ; William J. Sasiela ; Jay Edelberg ; Michael J. Louie ; Frederick J. Raal | Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program). |
| 001F75 (2016) |
Antoni Ribas ; Omid Hamid ; Adil Daud ; F Stephen Hodi ; Jedd D. Wolchok ; Richard Kefford ; Anthony M. Joshua ; Amita Patnaik ; Wen-Jen Hwu ; Jeffrey S. Weber ; Tara C. Gangadhar ; Peter Hersey ; Roxana Dronca ; Richard W. Joseph ; Hassane Zarour ; Bartosz Chmielowski ; Donald P. Lawrence ; Alain Algazi ; Naiyer A. Rizvi ; Brianna Hoffner ; Christine Mateus ; Kevin Gergich ; Jill A. Lindia ; Maxine Giannotti ; Xiaoyun Nicole Li ; Scot Ebbinghaus ; S Peter Kang ; Caroline Robert | Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. |
| 001F89 (2016) |
Steven E. Nissen ; Erik Stroes ; Ricardo E. Dent-Acosta ; Robert S. Rosenson ; Sam J. Lehman ; Naveed Sattar ; David Preiss ; Eric Bruckert ; Richard Ceška ; Norman Lepor ; Christie M. Ballantyne ; Ioanna Gouni-Berthold ; Mary Elliott ; Danielle M. Brennan ; Scott M. Wasserman ; Ransi Somaratne ; Rob Scott ; Evan A. Stein | Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. |
| 002075 (2016) |
William J. Sandborn ; Jean-Frédéric Colombel ; Subrata Ghosh ; Bruce E. Sands ; Gerald Dryden ; Xavier Hébuterne ; Rupert W. Leong ; Brian Bressler ; Thomas Ullman ; Peter L. Lakatos ; Walter Reinisch ; Li-An Xu ; Allison Luo | Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study. |
| 002513 (2016) |
Selma Ugurel ; Joachim Röhmel ; Paolo A. Ascierto ; Keith T. Flaherty ; Jean Jacques Grob ; Axel Hauschild ; James Larkin ; Georgina V. Long ; Paul Lorigan ; Grant A. Mcarthur ; Antoni Ribas ; Caroline Robert ; Dirk Schadendorf ; Claus Garbe | Survival of patients with advanced metastatic melanoma: The impact of novel therapies. |
| 002625 (2015) |
Marc Peeters ; Kelly S. Oliner ; Timothy J. Price ; Andrés Cervantes ; Alberto F. Sobrero ; Michel Ducreux ; Yevhen Hotko ; Thierry André ; Emily Chan ; Florian Lordick ; Cornelis J A. Punt ; Andrew H. Strickland ; Gregory Wilson ; Tudor E. Ciuleanu ; Laslo Roman ; Eric Van Cutsem ; Pei He ; Hua Yu ; Reija Koukakis ; Jan-Henrik Terwey ; Andre S. Jung ; Roger Sidhu ; Scott D. Patterson | Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer. |
| 002669 (2015) |
Sergio Giralt ; Laurent Garderet ; Brian Durie ; Gordon Cook ; Gosta Gahrton ; Benedetto Bruno ; Paremesweran Hari ; Henk Lokhorst ; Phillip Mccarthy ; Amrita Krishnan ; Pieter Sonneveld ; Harmut Goldschmidt ; Sundar Jagannath ; Bart Barlogie ; Maria Mateos ; Peter Gimsing ; Orhan Sezer ; Joseph Mikhael ; Jin Lu ; Meletios Dimopoulos ; Amitabha Mazumder ; Antonio Palumbo ; Rafat Abonour ; Kenneth Anderson ; Michel Attal ; Joan Blade ; Jenny Bird ; Michele Cavo ; Raymond Comenzo ; Javier De La Rubia ; Hermann Einsele ; Ramon Garcia-Sanz ; Jens Hillengass ; Sarah Holstein ; Hans Erik Johnsen ; Douglas Joshua ; Guenther Koehne ; Shaji Kumar ; Robert Kyle ; Xavier Leleu ; Sagar Lonial ; Heinz Ludwig ; Hareth Nahi ; Anil Nooka ; Robert Orlowski ; Vincent Rajkumar ; Anthony Reiman ; Paul Richardson ; Eloisa Riva ; Jesus San Miguel ; Ingemar Turreson ; Saad Usmani ; David Vesole ; William Bensinger ; Muzaffer Qazilbash ; Yvonne Efebera ; Mohamed Mohty ; Christina Gasparreto ; James Gajewski ; Charles F. Lemaistre ; Chris Bredeson ; Phillipe Moreau ; Marcelo Pasquini ; Nicolaus Kroeger ; Edward Stadtmauer | American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma. |
| 002757 (2015) |
Pablo Engel ; Laurence Boumsell ; Robert Balderas ; Armand Bensussan ; Valter Gattei ; Vaclav Horejsi ; Bo-Quan Jin ; Fabio Malavasi ; Frank Mortari ; Reinhard Schwartz-Albiez ; Hannes Stockinger ; Menno C. Van Zelm ; Heddy Zola ; Georgina Clark | CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology. |
